Evonik Expands Lafayette, Indiana, Operations
06/03/2022
The complex, located at 1650 Lilly Road, will be one of the largest sites for active pharmaceutical ingredients and Evonik's second-largest site in the U.S. employing 650 people. The expansion will allow the rapid and flexible production of a variety of lipids that may serve future applications of mRNA technology in infectious disease control, cancer immunotherapy, protein replacement and gene therapy. The additional space also ensures a rapid and extensive supply of lipids to fuel the continuing battle against COVID-19.
“With this investment in lipid production, we are further expanding our leading position on the global market and specifically strengthening our Health Care business,” said Evonik CEO Christian Kullmann. “It supports our strategic transformation into ‘Next Generation Evonik’, contributing value-added solutions with superior environmental and socio-economic profiles to our customers.”
Pending approval by the Indiana Economic Development Corporation (IEDC) board of directors, the IEDC will commit an investment in Evonik Corporation of up to $2.1 million in the form of incentive-based tax credits and up to $250,000 in conditional training grants. The IEDC will also offer up to $3 million from the Hoosier Business Investment (HBI) tax credit program based on the company’s planned capital investment in Indiana. These tax credits are performance-based, meaning the company is eligible to claim incentives once Hoosiers are hired and trained. The Greater Lafayette Commerce and Duke Energy offered additional incentives.
The company also received up to $150 million in funding for this project from the Biomedical Advanced Research and Development Authority (BARDA), a component of the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services. BARDA promotes the advanced development of medical countermeasures to respond to 21st century health security threats.
“Indiana is increasingly a leader in medical innovation due to the clustering of quality companies like Evonik that bring high wages and future-focused industry to our state," said Indiana Secretary of Commerce Brad Chambers.
Evonik Industries AG is headquartered in Essen, North Rhine-Westphalia, Germany. The company is the second-largest chemicals company in Germany, and one of the largest specialty chemicals companies in the world.
“Evonik’s strategic expansion at Tippecanoe is fantastic news for the entire Greater Lafayette region,” said Scott Walker, president and CEO of Greater Lafayette Commerce. “The town of Shadeland, Lafayette, West Lafayette, Tippecanoe County, the Purdue Research Foundation and Greater Lafayette Commerce all supported this effort and not only look forward to the high-value jobs it will create, but also the important role the new Lipid Center of Excellence will play in our nation’s vaccine preparedness.”
Throughout the COVID-19 pandemic, Evonik supplied lipids to the Pfizer/BioNTech COVID-19 vaccine and vaccination campaigns worldwide. The company has been supplying global pharmaceutical companies with the lipids needed for use with mRNA active ingredients.
Project Announcements
Western Smokehouse Partners Plans Mexico, Missouri, Manufacturing Operations
11/02/2024
Ridgenet Network Group Expands Pulaski County, Kentucky, Manufacturing Operations
11/02/2024
BENTELER Automotive Corporation Expands Duncan. South Carolina, Operations
11/02/2024
Graham Packaging Expands Tangipahoa Parish, Louisiana, Production Operations
10/30/2024
OmniaBio Plans Hamilton, Ontario, Manufacturing Operations
10/30/2024
Northern Hardwoods Lumber Upgrades Houghton County, Michigan, Operations
10/30/2024
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
The Role of Rail in Industrial Development
Q4 2024
-
Cold Storage: The Next Big Thing in Industrial Real Estate
Q3 2024
-
Which AI Tools Work for Job Recruiters?
Q3 2024
-
Exploring the Dynamic Landscape of Industrial Packaging Solutions
Q3 2024
-
Permitted Power Capacity Foreshadows Health of Regional Economies
Q3 2024
-
What If the Longshoremen's Strike Had Persisted? Examining the Potential Economic Fallout
Q4 2024